Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519161) titled 'Pharmacological Intervention to Prevent NOAF After TAVR' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Shanghai East Hospital
Condition:
Atrial Fibrillation
Intervention:
Drug: Metoprolol succinate
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 7, 2026
Target Sample Size: 198
To know more, visit https://clinicaltrials.gov/study/NCT07519161
Published by HT Digital Content Services with permission from Health Daily Diges...